5 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at the 5 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to check out more stocks and learn about Mr.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Hedge Fund and Insider Trading News: Dalton Investments, Balyasny Asset Management, Livermore Partners, IsZo Capital Management, Sarepta Therapeutics Inc (SRPT), Tabula Rasa HealthCare Inc (TRHC), and More
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
5 Stocks Cathie Wood is Selling
In this article, we discuss Tesla and the 4 other stocks that Cathie Wood is selling.
11 Best Genomic Stocks to Buy Now
Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, which refer to the complete set of DNA of an organism, as opposed to genetics, which is...
Should I Buy Sarepta Therapeutics Inc (SRPT)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Cathie Wood is Getting Rid of These 10 Stocks
Cathie Wood, the chief of New York-based ARK Investment Management, has become famous on Wall Street in recent years for her aggressive bets on technology stocks.
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Here's Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here.
Is SRPT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Sarepta Therapeutics (SRPT): Down 50%
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a commercial-stage biotechnology company engaged in developing unique RNA-targeted therapies and gene therapies for treating rare diseases.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
